¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"interaction process analysis"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
antigen analysis
Ç׿øºÐ¼®
arterial blood gas analysis
µ¿¸ÆÇ÷°¡½ººÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
age-period cohort analysis
¿¬·É±â°£ÄÚȣƮºÐ¼®
analysis
ºÐ¼®
birth cohort analysis
Ãâ»ýÄÚȣƮºÐ¼®
clinical decision analysis
ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
clonal analysis
Ŭ·ÐºÐ¼®
cluster analysis
¹«¸®ºÐ¼®
cohort analysis
ÄÚȣƮºÐ¼®
computer-assisted semen analysis
ÄÄÇ»ÅÍÁ¤¾×°Ë»ç
computerized image analysis
ÄÄÇ»ÅÍ¿µ»óºÐ¼®
control analysis
ÁöµµºÐ¼®
cost-benefit analysis
ºñ¿ëÆíÀͺм®
cost-effectiveness analysis
ºñ¿ëÈ¿°úºÐ¼®
ÀÌÀü
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
6
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
remodeling process
ÀçÇü¼º°úÁ¤
spinous process
°¡½Ãµ¹±â
styloid process
º×µ¹±â, °æ»óµ¹±â
transverse process
°¡·Îµ¹±â
zygomatic process
±¤´ëµ¹±â
self-analysis
ÀÚ±âºÐ¼®
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
tissue interaction
Á¶Á÷»óÈ£ÀÛ¿ë
analysis
ºÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®, ¹æ»çȺм®
age-period cohort analysis
¿¬·É±â°£ÄÚȣƮºÐ¼®
antigen analysis
Ç׿øºÐ¼®
birth cohort analysis
Ãâ»ýÄÚȣƮºÐ¼®
case analysis
Áõ·ÊºÐ¼®
clinical decision analysis
ÀÓ»óÀÇ»ç°áÁ¤ºÐ¼®
clonal analysis
Ŭ·ÐºÐ¼®
cluster analysis
¹«¸®ºÐ¼®
cohort analysis
ÄÚȣƮºÐ¼®
computer-assisted semen analysis
ÄÄÇ»ÅÍÁ¤¾×°Ë»ç
computerized image analysis
ÄÄÇ»ÅÍ¿µ»óºÐ¼®
control analysis
ÁöµµºÐ¼®
cost-benefit analysis
ºñ¿ëÆíÀͺм®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
interaction, T-B cell
T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
interaction, T-T cell
T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
interaction, primary
ÀÏÂ÷»óÈ£ÀÛ¿ë
photon interaction
±¤ÀÚ»óÈ£ÀÛ¿ë
radiation interaction
¹æ»ç¼± »óÈ£ÀÛ¿ë
receptor-ligand interaction
¼ö¿ëü-¹èÀ§ÀÚ »óÈ£ÀÛ¿ë
DNA sequence analysis
DNA ¼¿ºÐ¼®
Data analysis
Á¤º¸ºÐ¼®
Decision analysis
°áÁ¤ºÐ¼®
activation analysis
Ȱ¼ºÈºÐ¼®(¡ÝÂà°), ¹æ»çÈ(Û¯ÞÒûù)ºÐ¼®.
activation analysis
¹æ»çȺм®, Ȱ¼ºÈºÐ¼®
amniotic fluid analysis
¾ç¼öºÐ¼®
analysis
ºÐ¼®
analysis of variance technique
ºÐ»ê±â¼úºÐ¼®
analysis, antigen
Ç׿øºÐ¼®
ÀÌÀü
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
drug interaction
¾à¹° »óÈ£ÀÛ¿ë
drug interaction
¾à¹°»óÈ£ÀÛ¿ë.
drug interaction
¾à¹°»óÈ£ÀÛ¿ë(å·ÚªßÓû»íÂéÄ).
drugs,interaction
»óÈ£ÀÛ¿ë(ßÓû»íÂéÄ)
genetic interaction
À¯ÀüÀû »óÈ£ÀÛ¿ë
heme heme interaction
Çð-Çð »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
heme heme interaction
Èû-Èû »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
infant-mother interaction
¿µ¾Æ-¸ð »óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë(ßÓû»íÂéÄ).
interaction, T-B cell
T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
interaction, T-T cell
T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
interaction, primary
ÀÏÂ÷»óÈ£ÀÛ¿ë
intermolecular dipole dipole interaction
ºÐÀÚ°£ ½Ö±ØÀÚ°£ »óÈ£ÀÛ¿ë
intramolecular dipole dipole interaction
ºÐÀÚ³» ½Ö±ØÀÚ°£ »óÈ£ÀÛ¿ë
ÀÌÀü
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
2
¿µ¹®
ÇѱÛ
ÀÌÀü
ÅëÇÕ°Ë»ö ¿Ï·á
ÀÌÀü
´ÙÀ½